Prevalence and determinants of anemia in older people with diabetes attending an outpatient clinic: A cross-sectional audit

Clinical Diabetes

Volumn 32, Issue 4, 2014, Pages 158-162

  Trevest, Katie ^a   Treadway, Hannah ^a   Hawkins Van Der Cingel, Gerlineke ^a   Bailey, Claire ^a   Abdelhafiz, Ahmed H ^a  

^a ROTHERHAM GENERAL HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOTENSIN RECEPTOR ANTAGONIST; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; METFORMIN; PIOGLITAZONE;

AGED; ANEMIA; ARTICLE; CHRONIC KIDNEY DISEASE; CROSS-SECTIONAL STUDY; DIABETES MELLITUS; EVALUATION AND FOLLOW UP; FEMALE; HEMOGLOBIN BLOOD LEVEL; HUMAN; INTERVIEW; LOGISTIC REGRESSION ANALYSIS; LONG TERM CARE; MAJOR CLINICAL STUDY; MALE; MEDICAL AUDIT; OUTPATIENT DEPARTMENT; PREVALENCE; SOCIAL DETERMINANTS OF HEALTH; VERY ELDERLY;

EID: 84908005445     PISSN: 08918929     EISSN: None     Source Type: Journal    
DOI: 10.2337/diaclin.32.4.158     Document Type: Article

References (18)

1. Patel KV: Epidemiology of anemia in older adults. Semin Hematol 45:210–217, 2008
2. Thomas MC, MacIsaac RJ, Tsalamandris C, Molyneaux L, Goubina I, Fulcher G, Yue D, Jerums G: The burden of anaemia in type 2 diabetes and the role of nephropathy: a cross-sectional audit. Nephrol Dial Transplant 19:1792–1797, 2004
3. Lash AA, Coyer SM: Anemia in older adults. Medsurg Nurs 17:298–304, 2008
4. den Elzen WP, Willems JM, Westendorp RG, de Craen AJ, Assendelft WJ, Gussekloo J: Effect of anemia and comorbidity on functional status and mortality in old age: results from the Leiden 85-Plus Study. CMAJ 181:151–157, 2009
5. Riva E, Tettamanti M, Mosconi P: Association of mild anemia with hospitalization and mortality in the elderly: the Health and Anemia population-based study. Haematologica 94:22–28, 2009
6. Makipour S, Kanapuru B, Ershler WB: Unexplained anemia in the elderly. Semin Hematol 45:250–254, 2008
7. Tettamanti M, Lucca U, Gandini F, Recchia A, Mosconi P, Apolone G, Nobili A, Tallone MV, Detoma P, Giacomin A, Clerico M, Tempia P, Savoia L, Fasolo G, Ponchio L, Porta MGD, Riva E: Prevalence, incidence and types of mild anemia in the elderly: the “Health and Anemia” population-based study. Haematologia 95:1849–1856, 2010
8. Klahr S, Levey AS, Beck GJ, Caggiula AW, Hunsicker L, Kusek JW, Striker G: The effects of dietary protein restriction and blood-pressure control on the progression of renal disease. Modification of Diet in Renal Disease Study Group. N Engl J Med 330:877–884, 1994
9. Guralnik JM, Eisenstaedt RS, Ferrucci L, Klein HG, Woodman RC: Prevalence of anemia in persons 65 years and older in the United States: evidence for a high rate of unexplained anemia. Blood 104:2263–2268, 2004
10. Davey A, Lele U, Elias MF, Dore GA, Siegler IC, Johnson MA, Hausman DB, Tenover JL, Poon LW: Diabetes mellitus in centenarians. J Am Geriatr Soc 60:468–473, 2012
11. Zakai NA, French B, Arnold AM, Newman AB, Fried LF, Robbins J, Chaves P, Cushman M: Hemoglobin decline, function, and mortality in the elderly: the Cardiovascular Health Study. Am J Hematol 88:5–9, 2013
12. Chagai G, Dovrish Z, Nira KM, Bornstein G, Leibowitzet A: Diabetes mellitus with normal renal function is associated with anemia. Diabetes Metab Res Rev 30:291–296, 2014
13. Liu KW, Dai DLK, Ho W, Lau E, Woo J: Metformin-associated vitamin B deficiency in the elderly. Asian J Gerontol Geriatr 6:82–87, 2011
14. Berria R, Glass L, Mahankali A, Miyazaki Y, Monroy A, De Filippis E, Cusi K, Cersosimo E, DeFronzo RA, Gastaldelli A: Reduction in hematocrit and hemoglobin following pioglitazone treatment is not hemodilutional in type II diabetes mellitus. Clin Pharmacol Ther 82:275–281, 2007
15. Leshem-Rubinow E, Steinvil A, Zeltser D, Berliner S, Rogowski O, Chodick G, Shalev V: Association of angiotensin-converting enzyme inhibitor therapy initiation with a reduction in hemoglobin levels in patients without renal failure. Mayo Clin Proc 87:1189–1195, 2012
16. Mohanram A, Zhang Z, Shahinfar S, Lyle PA, Toto RD: The effect of losartan on hemoglobin concentration and renal outcome in diabetic nephropathy of type 2 diabetes. Kidney Int 73:630–636, 2008
17. Hammerman-Rozenberg R, Jacobs JM, Azoulay D, Stessman J: Aspirin prophylaxis and the prevalence of anaemia. Age Ageing 35:514–517, 2006
18. Singh AK, Szczech L, Tang KL, Barnhart H, Sapp S, Wolfson M, Reddan D: Correction of anemia with epoetin alfa in chronic kidney disease. N Engl J Med 355:2085–2098, 2006